Harrow, Inc.
Pharmaceutical company · Nashville, Tennessee, United States · Nasdaq: HROW
Harrow, Inc. is a pharmaceutical company headquartered in Nashville, Tennessee, United States. Its shares trade on Nasdaq under the ticker HROW. It has reported private securities offerings to the US SEC, most recently $11 million sold in a notice filed in 2021.
Harrow at a glance
What does Harrow do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $10.7 million sold (2021).
Frequently asked questions about Harrow
Where is Harrow headquartered?
Harrow, Inc. is headquartered in Nashville, Tennessee, United States.
What does Harrow do?
Harrow, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Harrow a public company?
Yes. Harrow, Inc. trades on Nasdaq under the ticker HROW.
Similar companies
- Cumberland Pharmaceuticals IncNashville, Tennessee, United States
- Revance Therapeutics, Inc.Nashville, Tennessee, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.